Canada Pension Plan Investment Board’s Vera Therapeutics VERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$511K Sell
11,900
-109,000
-90% -$4.06M ﹤0.01% 1256
2026
Q1
$4.86M Buy
120,900
+300
+0.2% +$12.9K ﹤0.01% 768
2025
Q4
$6.11M Buy
120,600
+18,400
+18% +$654K ﹤0.01% 744
2025
Q3
$2.97M Buy
+102,200
New +$2.36M ﹤0.01% 847

Other funds holding VERA

Canada Pension Plan Investment Board's VERA Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Vera Therapeutics (VERA) stake by 90% in Q2 2026, selling an estimated $4.06M and leaving 11,900 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Canada Pension Plan Investment Board first reported a position in VERA in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.11M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Canada Pension Plan Investment Board held 11,900 shares of Vera Therapeutics worth $511K as of Q2 2026.
  • Canada Pension Plan Investment Board sold 109,000 Vera Therapeutics shares in Q2 2026, an estimated $4.06M.
  • Vera Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1256 holding.
  • Canada Pension Plan Investment Board first reported a position in Vera Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's Vera Therapeutics position peaked at $6.11M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.